diagnosis and treatment of infertility, first/second/third generation IVF (including
egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
disease
diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
clinical
technology applications. Many of these technologies are at the leading level both domestically
and
internationally.
First, why is the "success rate of video consultation" attracting more and more attention?
In actual consultation, an obvious trend is:
Many people don't ask "where to do it" first, but ask first-
"The doctor said in the video that the success rate is very high. Is this reliable?"
In essence, this is not a technical problem, but an information screening problem.
Because IVF is a highly individualized medical behavior, the "success rate" seen by different people is not in the same dimension.

Second, the first principle: what does the success rate mean?
The success rate ≠ the probability of success once.
More commonly used in medicine is:
Clinical pregnancy rate
Live yield (more core)
Cumulative success rate
In general:
The success rate of single transplantation is about 20%-40%.
Multi-cycle cumulative success rate can be significantly improved.
But the key question is:
Different institutions have different statistical caliber.
Third, three common misunderstandings of "success rate" in video consultation
Myth 1: Take "the highest population data" as your own reference.
Many institutions show:
Data of young women
High quality embryo data
Screening data using PGT
All these will raise the result.
But the truth is:
< 35 years old: about 50%
Over 40 years old: obviously decreased.
Over 43 years old: may enter the single-digit range.
Conclusion: We must look at "data of the same age group"
Myth 2: Confuse "egg supply data"
Egg donors usually:
Younger.
Egg quality is more stable.
Will significantly increase the success rate.
But it does not represent its own situation.
Myth 3: Ignore the "transplant live rate"
The real key indicators are:
Live birth rate after each embryo transfer
Instead of:
Egg retrieval success rate
fertilization rate
Fourth, the core variables that affect the success rate
From a medical point of view, there are only four core variables:
1 Age (with the highest weight)
Egg quality determines the upper limit
The probability of chromosome abnormality increases with age.
2 embryo quality
Blastocyst or not
Screening (PGT)
3 laboratory level
Culture system
Embryo screening ability
Laboratory differences will directly affect the results.
4 uterine environment
Intima thickness
Do you have fibroids/inflammation?
V. Difference of success rate and cost of test tubes in different countries
At present, there are roughly three paths for popular countries:
Path 1: Technology-oriented (such as the United States)
Transparent success rate data
Mature technology
High cost (about $30,000 or more)
Path 2: Cost-effective orientation (such as Thailand and Greece)
Medium-high success rate
The cost is relatively controllable.
In some countries, the range is about 40,000-60,000 yuan.
Path 3: Emerging markets (such as Central Asia/parts of Eastern Europe)
Lower cost
Information transparency varies greatly.
Need to focus on screening institutions
Six, video consultation, it is recommended to focus on five questions.
Ask core questions template:
What age group is your success rate?
Is there a distinction between self-fertilized eggs and donor eggs?
Is it a "live transplantation rate"?
How many times does it take eggs for each live birth?
Is embryo screening (PGT) used?
Decision model: How to judge whether a scheme is reasonable?
You can use a simple judgment model:
Judgment logic:
Dimension key point
Whether the authenticity of data is classified by age and type?
Does the cost structure include hidden expenses?
Is there an independent laboratory for medical capacity?
Is the scheme matching personalized?
VIII. Frequently Asked Questions
Q1: Is the success rate of overseas test tubes generally higher?
Not necessarily.
The success rate depends on age+embryo quality+laboratory level, not the country itself.
Q2: Can video consultation judge the success rate?
Preliminary assessment is possible, but it cannot replace:
Hormone examination
AMH detection
Semen analysis
Q3: Why do some people succeed once and others fail many times?
Because:
Large individual differences
The essence of success rate is probability.
Studies have shown that the cumulative success rate has been significantly improved after many attempts.
Q4: Are institutions with high success rates necessarily better?
Not necessarily, need to be vigilant:
data screening
Crowd deviation
Statistical caliber difference
IX. Summary
In a word, the core conclusion:
The success rate of test tube is not a fixed number, but a comprehensive result of "age+embryo+technology+uterine environment".
Judge priority:
Look at the success rate corresponding to age first.
Let's see if it's "transplant live rate"
Finally, see if the hospital data is transparent.
X. Critical assessment
superiority
Choose more overseas.
Technical differences bring space.
The cost structure is more flexible
risk
Information Asymmetry
The success rate is misread
Over-reliance on "video consultation judgment"
Technology-assisted fertility, fulfilling dreams of thousands of families

